Coronavirus update: India's coronavirus recovery rate has risen to 68.3 per cent and the fatality rate has declined to 2.04 per cent

The task force will also chalk out a budget and discuss how capital can be raised for procurement, distribution of the vaccine

Coronavirus vaccine update: Serum Institute of India might begin its Phase 2 and 3 clinical trials in India within a week. Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate are going on in the United Kingdom, phase 3 clinical trial in Brazil

SII has already joined hands with Astra Zeneca and Novavax to develop their coronavirus candidates

The vaccine formulated by the Gamaleya Institute is currently undergoing clinical trials at two sites -- Burdenko Main Military Clinical Hospital and the Sechenov First Moscow State Medical University

Coronavirus vaccine news update: Serum Institute of India would have exclusive rights for the supply of the Novavax COVID-19 vaccine in India

Independent research has found RFL-100 can block COVID-19's replication in human lung cells and monocytes; no other antiviral agent has demonstrated rapid recovery from viral infection and demonstrated laboratory inhibition of viral replication, says Jonathan Javitt, CEO, NeuroRx

The spike of coronavirus past the 20-lakh mark has made India inch closer to become the ground zero of COVID-19 outbreak

Microsoft aims to buy TikTok's entire global businessMicrosoft Corp is chasing a deal to buy all of TikTok's global business. However, a source familiar with the discussions told Reuters that Microsoft had not raised the prospect of buying all of TikTok in its negotiations with ByteDance. Microsoft had said it was seeking to buy the assets of TikTok in North America, Australia and New Zealand.COVID-19 vaccine: US to pay $1 billion for 100 million doses of J&J's potential candidateThe U...

Though margins remain healthy, pricing pressures for the US base generics business, lack of limited competition products and manufacturing quality issues will continue to trouble them, said ICRA

A giant feast took place in the heart of Mumbai amid a national lockdown. One of India's top ice-cream makers had given away 26 tonnes of their best product for free. But, those consuming the ice-cream weren't sugar-craving humans

U.S. crude oil stockpiles fell sharply last week as refining rates hit their highest since March, while gasoline and distillate inventories rose, the Energy Information Administration said; Novavax Inc has entered a supply and license agreement with the Serum Institute of India for the development and commercialisation of its COVID-19 vaccine candidate; Food brands today are riding the wave of 'immunity boosting products' led by consumer demand. Watch this and more news on News Blast.Also Read: RBI keeps repo rate unchanged at 4%, maintains status quo

On Tuesday, Novavax reported that its experimental Covid-19 vaccine produced high levels of antibodies against the novel coronavirus in a small, early-stage clinical trial, and that it could start a large pivotal Phase III trial as soon as late September

Coronavirus impact: Banks, NBFCs to face asset quality distress, says ICRAIndia's banks and non-banking financial companies (NBFCs) will continue to face elevated asset quality risks even as most of them reported a decline in the loans under moratorium provided by the Reserve bank of India (RBI) to borrowers on their loan repayments, as per a latest report. This was attributed to the impact of the coronavirus pandemic on borrowers' repayment capabilities.US crude oil stockpiles tumble sharp...

Last week, Moderna announced the start of a late-stage trial on 30,000 people to demonstrate that its vaccine is safe and effective, the final hurdle prior to regulatory approval

Share market updates and analysis for August 6: RBI policy announcement, earnings announcements and global cues to set tone for stock markets

Coronavirus recovery rate improves to 67.19 per cent, while mortality rate drops to 2.09 per cent. Health ministry says aggressive testing has led to improvement of recovery rate

The vaccine, using the platform of plasmid DNA, was found to be safe and well tolerated in the Phase I, which began on 15 July, said Zydus Cadila

Coronavirus vaccine news update: The Phase II trial will evaluate the humoral and cellular immune response for the coronavirus vaccine candidate, keeping in line with the current global protocols

Top Indian and global CEOs and experts on why the future is bright